Paraneoplastic myopathy in pancreatic cancer: a case report and literature review

References

• Sigurgeirsson B, Lindelöf B, Edhag O, et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326(6):363–367.
   PubMed Web of Science ®Google Scholar
• Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010;85(9):838–854.
   PubMed Web of Science ®Google Scholar
• Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev. 2010;9(6):449–453.
   PubMed Web of Science ®Google Scholar
• Meyer A, Meyer N, Schaeffer M, et al. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford). 2015;54(1):50–63.
   PubMed Web of Science ®Google Scholar
• Tan JA, Roberts-Thomson PJ, Blumbergs P, et al. Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases. Int J Rheum Dis. 2013;16(3):331–338.
   Web of Science ®Google Scholar
• Ponyi A, Constantin T, Garami M, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005;1051:64–71.
   PubMed Web of Science ®Google Scholar
• Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96–100.
   PubMed Web of Science ®Google Scholar
• Croce S, Guèye M, Korganow AC, et al. Paraneoplastic polymyositis associated with breast cancer: a therapeutic emergency. Breast Cancer Res Treat. 2011;126(3):811–814.
   Web of Science ®Google Scholar
• Merali N, Yousuff M, Pronisceva V, et al. Paraneoplastic polymyositis presenting as a clinically occult breast cancer. Ann R Coll Surg Engl. 2017;99(2):e40–e43.
   Web of Science ®Google Scholar
• Dias LP, Faria AL, Scandiuzzi MM, et al. A rare case of severe myositis as paraneoplastic syndrome on breast cancer. World J Surg Oncol. 2015;13:134.
   Web of Science ®Google Scholar
• Gabrilovich M, Raza M, Dolan S, et al. Paraneoplastic polymyositis associated with squamous cell carcinoma of the lung. Chest. 2006;129(6):1721–1723.
   Web of Science ®Google Scholar
• Acciavatti A, Avolio T, Rappuoli S, et al. Paraneoplastic necrotizing myopathy associated with adenocarcinoma of the lung - a rare entity with atypical onset: a case report. J Med Case Rep. 2013;7:112.
   PubMedGoogle Scholar
• Fujita J, Tokuda M, Bandoh S, et al. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int. 2001;20(2):81–84.
   Web of Science ®Google Scholar
• Uchibori K, Ogata T, Shirai T, et al. Lung cancer diagnosed more than five years after the development of polymyositis/dermatomyositis. ISRN Pulmonol. 2013;2013:1–6.
   Google Scholar
• Syrios J, Kechagias G, Xynos ID, et al. Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC Gastroenterol. 2011;11:33.
   Web of Science ®Google Scholar
• Rominiyi O, Broman DM, Rajaganeshan R, et al. Colon cancer presenting with polymyositis-A case report. Int J Surg Case Rep. 2011;2(7):225–227.
   Google Scholar
• Yang Z, Lin F, Qin B, et al. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2015;42(2):282–291.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Wu CY, Huang YL, et al. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther. 2010;12(2):R70.
   PubMed Web of Science ®Google Scholar
• Buchbinder R, Forbes A, Hall S, et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med. 2001;134(12):1087–1095.
   PubMed Web of Science ®Google Scholar
• Kida Y, Maeshima E, Furukawa K, et al. A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer. Mod Rheumatol. 2007;17(3):262–264.
   PubMedGoogle Scholar
• Siddiqui S, Fiorillo M, Tzeng J, et al. Polymyositis as a paraneoplastic phenomenon of occult pancreatic cancer. Am J Gastroenterol. 2011;106:S220.
   Web of Science ®Google Scholar
• Amroun KL, De Mestier L, Deguelte-Lardiere S, et al. Pancreas cancer-associated polymyositis of the legs regressing after cephalic duodenopancreatectomy: case report and review of the literature. JOP. 2012;13(6):674–676.
   Google Scholar
• Spielmann L, Messer L, Moreau P, et al. Gemcitabine-induced myopathy. Semin Arthritis Rheum. 2014;43(6):784–791.
   Web of Science ®Google Scholar
• Burris HA 3rd, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15(11):1227–1237.
   PubMed Web of Science ®Google Scholar
• Ardavanis AS, Ioannidis GN, Rigatos GA. Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel. Anticancer Res. 2005;25(1B):523–525.
   Web of Science ®Google Scholar
• Huang ZG, Gao BX, Chen H, et al. An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis. PloS One. 2017;12(7):e0181069.
   Web of Science ®Google Scholar
• O’Connell MJ, Powell T, Brennan D, et al. Whole-body MR imaging in the diagnosis of polymyositis. AJR Am J Roentgenol. 2002;179(4):967–971.
   Web of Science ®Google Scholar
• Shovman O, Gilburd B, Chayat C, et al. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Immunol Res. 2017;65(1):276–281.
   Web of Science ®Google Scholar
• Joffe MM, Love LA, Leff RL, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med. 1993;94(4):379–387.
   PubMed Web of Science ®Google Scholar
• Ghate J, Katsambas A, Augerinou G, et al. Review article: a therapeutic update on dermatomyositis/polymyositis. Int J Dermatol. 2000;39(2):81–87.
   Web of Science ®Google Scholar
• Bronner IM, Hoogendijk JE, Wintzen AR, et al. Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy. J Neurol. 2003;250(4):480–485.
   Web of Science ®Google Scholar
• van Dijk S, van der Kooi AJ, Aronica E, et al. Paraneoplastic necrotizing autoimmune myopathy in a patient undergoing laparoscopic pancreatoduodenectomy for distal cholangiocarcinoma. Case Rep Gastroenterol. 2016;10(3):525–530.
   Google Scholar
• András C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol. 2008;35(3):438–444.
   PubMed Web of Science ®Google Scholar
• Carpenter JR, Bunch TW, Engel AG, et al. Survival in polymyositis: corticosteroids and risk factors. J Rheumatol. 1977;4(2):207–214.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Oddis CV. Paraneoplastic myalgias and myositis. Rheum Dis Clin North Am. 2011;37(4):607–621.
   Web of Science ®Google Scholar
• Maugars YM, Berthelot JM, Abbas AA, et al. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol. 1996;14(3):263–274.
   PubMed Web of Science ®Google Scholar